ALXN : Analysis & Opinions

  1. Alexion Seeks Expanded Use for Soliris in US and EU

    January 10, 2017
    Alexion files for label expansion for its drug Soliris in both the US and the EU.
  2. Alexion Blood Disorder Meds Wins Orphan Drug Status

    January 9, 2017
    Alexion's blood-disorder drug has now received orphan drug status in both the US and the EU.
  3. Alexion: Internal Probe Shows No Revenue Inflation

    January 6, 2017
    Alexion said an internal probe shows the company didn't improperly recognize revenue.
  4. Alexion’s Soliris Fails In Kidney Transplant Study

    January 4, 2017
    Alexion's expensive drug failed in a Phase 2/3 trial for treating organ transplant patients.
  5. Alexion Graft-Versus-Host Disease Gets ODD (ALXN)

    October 20, 2016
    Alexion's ALXN1007 drug to treat graft-versus-host disease secured orphan drug designation from the FDA.
  6. Alexion Gets U.K. Approval for High-Cost Drug (ALXN)

    September 23, 2016
    Though user base is small for this rare disease, the high annual cost of up to $2 million offers attractive commercials for ...
  7. Alexion’s ‘Uncommon Strength’ Campaign Offers a Win-Win (ALXN)

    September 14, 2016
    Amid a dearth of information on rare diseases, patients will benefit from the information sharing platform, and the company ...
  8. Top 10 Biotech Stocks for 2016 (ALXN, ALNY)

    August 30, 2016
    The biotechnology sector has many growth opportunities for the remainder of 2016. Here are the top ten biotech stocks, with ...
  9. Tesla Tops Forbes' 2016 List of Most Innovative Companies (TSLA, ...

    August 25, 2016
    Forbes has released its sixth annual "World’s Most Innovative Companies" and Tesla tops the list.
  10. 16 Recently Upgraded Stocks (APD,ALXN,ADP,BHI)

    July 13, 2016
    These 16 stocks were recently upgraded, which usually leads to bullish action.
  11. T Rowe Price Health Sciences Fund Performance Case Study (PRHSX)

    May 4, 2016
    Learn more about the T. Rowe Price Health Sciences Fund, including the historical performance and financial trends by quarter ...
  12. 5 Punished Stocks: Are They Bargains? (ENDP,VRTX)

    March 31, 2016
    These five stocks have been slammed recently. Does this mean they are now bargains?
  13. Portfolio Trends in 2016 (PRHSX)

    March 23, 2016
    Discover how the T. Rowe Price Health Sciences Fund is positioned in 2016, and learn what trends in the portfolio may help ...
  14. Why These Could Be 2015's 10-Best Pharma Stocks (ABBV, ALXN)

    March 17, 2015
    The pharmaceutical stocks covered here have significant potential going forward. Here's why.
  15. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...